Celcuity Management
Management criteria checks 4/4
Celcuity's CEO is Brian Sullivan, appointed in Jan 2012, has a tenure of 12.33 years. total yearly compensation is $1.74M, comprised of 12.1% salary and 87.9% bonuses, including company stock and options. directly owns 9.91% of the company’s shares, worth $49.17M. The average tenure of the management team and the board of directors is 3.3 years and 8.8 years respectively.
Key information
Brian Sullivan
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 12.1% |
CEO tenure | 12.3yrs |
CEO ownership | 9.9% |
Management average tenure | 3.3yrs |
Board average tenure | 8.8yrs |
Recent management updates
Recent updates
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?
Jul 04Is Celcuity (NASDAQ:CELC) A Risky Investment?
Sep 13Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment
Jul 18Is Celcuity (NASDAQ:CELC) A Risky Investment?
Jan 27Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?
Sep 21Celcuity: Nipping The Oncogenic Bud
Jul 08What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition
Mar 14We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely
Jan 20Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies
Dec 23Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?
Nov 29Celcuity EPS beats by $0.03
Nov 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$2m | US$210k | -US$64m |
Sep 30 2023 | n/a | n/a | -US$57m |
Jun 30 2023 | n/a | n/a | -US$49m |
Mar 31 2023 | n/a | n/a | -US$45m |
Dec 31 2022 | US$2m | US$106k | -US$41m |
Sep 30 2022 | n/a | n/a | -US$36m |
Jun 30 2022 | n/a | n/a | -US$31m |
Mar 31 2022 | n/a | n/a | -US$35m |
Dec 31 2021 | US$1m | US$260k | -US$30m |
Sep 30 2021 | n/a | n/a | -US$25m |
Jun 30 2021 | n/a | n/a | -US$22m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$469k | US$250k | -US$9m |
Sep 30 2020 | n/a | n/a | -US$9m |
Jun 30 2020 | n/a | n/a | -US$8m |
Mar 31 2020 | n/a | n/a | -US$8m |
Dec 31 2019 | US$992k | US$250k | -US$7m |
Sep 30 2019 | n/a | n/a | -US$7m |
Jun 30 2019 | n/a | n/a | -US$7m |
Mar 31 2019 | n/a | n/a | -US$7m |
Dec 31 2018 | US$564k | US$250k | -US$7m |
Sep 30 2018 | n/a | n/a | -US$7m |
Jun 30 2018 | n/a | n/a | -US$7m |
Mar 31 2018 | n/a | n/a | -US$7m |
Dec 31 2017 | US$490k | US$232k | -US$6m |
Compensation vs Market: Brian's total compensation ($USD1.74M) is about average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian Sullivan (61 yo)
12.3yrs
Tenure
US$1,738,115
Compensation
Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 12.3yrs | US$1.74m | 9.91% $ 49.2m | |
Co-Founder | 12.3yrs | US$1.48m | 4.1% $ 20.4m | |
Chief Financial Officer | 6.8yrs | US$898.74k | 0.054% $ 269.9k | |
Senior Vice President of R&D | 3.3yrs | no data | no data | |
Acting Head of Clinical Operations | 3.3yrs | no data | no data | |
Chief Medical Officer | 2.2yrs | no data | no data | |
Chief Commercial Officer | less than a year | no data | no data |
3.3yrs
Average Tenure
61yo
Average Age
Experienced Management: CELC's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 12.3yrs | US$1.74m | 9.91% $ 49.2m | |
Co-Founder | 12.3yrs | US$1.48m | 4.1% $ 20.4m | |
Independent Director | 7.3yrs | US$124.29k | 0.32% $ 1.6m | |
Independent Director | 10.3yrs | US$120.13k | 0.031% $ 152.0k | |
Independent Director | 5yrs | US$108.82k | 0.034% $ 171.2k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 5.3yrs | no data | no data |
8.8yrs
Average Tenure
65yo
Average Age
Experienced Board: CELC's board of directors are considered experienced (8.8 years average tenure).